Membranes and their constituents as promoters of calcium oxalate crystal formation in human urine

Calcified Tissue International

Volumn 66, Issue 2, 2000, Pages 90-96

  Khan, S R ^a   Maslamani, S A ^a   Atmani, F ^a   Glenton, P A ^a   Opalko, F J ^a   Thamilselvan, S ^a   Hammett Stabler, C ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Calcium oxalate; Cell membrane; Matrix Vesicles; Nephrolithiasis; Phospholipids

Indexed keywords

CALCIUM OXALATE; CHOLESTEROL; MEMBRANE PHOSPHOLIPID; MEMBRANE PROTEIN; OXALIC ACID; PHOSPHATIDIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL; SPHINGOMYELIN; TRIACYLGLYCEROL;

ARTICLE; CALCIUM OXALATE STONE; CENTRIFUGATION; CRYSTAL; ELECTRON MICROSCOPY; FILTRATION; HUMAN; KIDNEY TUBULE EPITHELIUM; LIPID COMPOSITION; MEMBRANE VESICLE; NEPHROLITHIASIS; PRIORITY JOURNAL; PROTEIN CONTENT; STONE FORMATION; URINE;

ANIMALS; CALCIUM OXALATE; CELL MEMBRANE; CRYSTALLIZATION; HUMANS; KIDNEY TUBULES; LIPIDS; MALE; MEMBRANE LIPIDS; MICROVILLI; PROTEINURIA; RATS; ULTRAFILTRATION; URINE;

EID: 0033958823     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002230010019     Document Type: Article

References (41)

1. Finlayson B (1978) Physico-chemical aspects of urolithiasis. Kidney Int 13:344-360
2. Kavanagh JP (1996) Calcium oxalate crystallization in vitro. In: Khan, SR (ed) Calcium oxalate in biological systems. CRC Press, Boca Raton, FL, pp 1-21
3. Khan SR (1995) Heterogeneous nucleation of calcium oxalate crystals in mammalian urine. Scann Micros 9:597-616
4. Irving JT, Wuthier RE (1968) Histochemistry and biochemistry of calcification with special reference to the role of lipids. Clin Orthop 56:237-260
5. Anderson HC (1969) Vesicles associated with calcification in the matrix of epiphyseal cartilage. J Cell Biol 59-72
6. Wuthier RE (1971) Zonal analysis of phospholipids in the epiphyseal cartilage and bone of normal and rachitic chickens and pigs. Calcif Tissue Res 8:36-53
7. Ali SY (1976) Analysis of matrix vesicles and their role in the calcification of epiphyseal cartilage. Fed Proc 35:135-142
8. Anderson HC (1980) Calcification processes. Pathol Annu 15:45-75
9. Boyan BD, Schwartz Z, Swain LD, Khare A (1989) Role of lipids in calcification of cartilage. Anat Rec 224:211-219
10. Boskey AL (1989) Phospholipids and calcification. In: Hukins DWL (ed) Calcified tissue. CRC Press, Boca Raton, FL, p 215
11. Raggio CL, Boyan BD, Boskey AL (1986) In vivo hydroxyapatite formation induced by lipids. J Bone Miner Res 1:409-415
12. Vogel JJ, Boyan-Salyers BD (1976) Acidic lipids associated with the local mechanism of calcification. Clin Orthop 118: 230-240
13. 4 complex. Calcif Tissue Res 225:197-201
14. Odutuga AA, Prout RES, Hoare RJ (1975) Hydroxyapatite precipitation in vitro by lipids extracted from mammalian dentine. Arch Oral Biol 20:311-315
15. Eanes ED, Hailer AW (1985) Liposome-mediated calcium phosphate formation in metastable solutions. Calcif Tissue Int 37:390-394
16. Khan SR, Shevock PN, Hackett RL (1988) In vitro precipitation of calcium oxalate in the presence of whole matrix or lipid components of the urinary stones. J Urol 139:8-422
17. Khan SR, Shevock PN, Hackett RL (1990) Membrane-associated crystallization of calcium oxalate in vitro. Calcif Tissue Int 46:116-120
18. Khan SR, Whalen PO, Glenton PA (1993) Heterogeneous nucleation of calcium oxalate crystals in the presence of membrane vesicles. J Crystal Growth 134:211-218
19. Hackett RL, Shevock PN, Khan SR (1990) Cell injury-associated calcium oxalate crystalluria. J Urol 144:1535-1538
20. Coe FL, Margolis HC, Deutsch LH, Strauss AL (1980) Urinary macromolecular crystal growth inhibitors in calcium nephrolithiasis. Miner Electrolyte Metab 3:268-275
21. Ryall RL, Harnett RM, Hibberd CM, Edyvane KA, Marshall VR (1991) Effects of chondroitin sulphate, human serum albumin and Tamm-Horsfall mucoprotein on calcium oxalate crystallization in undiluted human urine. Urol Res 19:181-187
22. Ryall RL, Hibberd CM, Marshall VR (1985) A method for studying inhibitory activity in whole urine. Urol Res 13:285-291
23. Khan SR, Shevock PN, Hackett RL (1988) Presence of lipids in urinary stones: results of preliminary studies. Calcif Tissue Int 42:91-96
24. Khan SR, Glenton PA (1996) Increased urinary excretion of lipids by patients with kidney stones. Br J Urol 77:506-511
25. Ryall RL, Stapleton AMF (1995) Urinary macromolecules in calcium oxalate stone and crystal matrix: good, bad, or indifferent? In: Khan SR (ed) Calcium oxalate in biological systems. CRC Press, Boca Raton, FL, pp 265-290
26. Khan SR (1997) Interactions between stone-forming calcific crystals and macromolecules. Urol Int 59:59-71
27. Schoen FJ, Harasaki H, Kim KM, Anderson HC, Levy RJ (1988) Biomaterial-associated calcification: pathology, mechanisms, and strategies for prevention. J Biomed Mater Res 22:(A1) 11-36
28. Boskey AL, Boyan-Salyers BD, Burstein LS, Mandel ID (1981) Lipids associated with mineralization of human submandibular gland sialoliths. Arch Oral Biol 26:779-785
29. Khan SR, Atmani F, Glenton P, Hou Z-C, Talham DR, Khurshid M (1996) Lipids and membranes in the organic matrix of urinary calcific crystals and stones. Calcif Tissue Int 59:357-365
30. Whipps S, Khan SR, Opalko FJ, Backov R, Talham DR (1998) Growth of calcium oxalate monohydrate at phospholipid Langmuir monolayers. J Crystal Growth 192:243-249
31. Khan SR, Hackett RL (1985) Calcium oxalate urolithiasis in the rat: Is it a model for human stone disease? A review of recent literature. Scan Electr Microsc 11:759-774
32. Hoyer JR (1994) Uropontin in urinary calcium stone formation. Miner Electrolyte Metab 20:385-392
33. Worcester EM, Blumenthal SS, Beshensky AM, Lewand DL (1992) The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin. J Bone Miner Res 7:1029-1036
34. Atmani F, Mizon J, Khan SR (1996) Identification of uronic-acid-rich protein as urinary bikunin, the light chain of inter-a-inhibitor. Eur J Biochem 236:984-990
35. Atmani F, Mizon J, Khan SR (1996) Inter-alpha-inhibitor: a protein family involved in the inhibition of calcium oxalate crystallization. Scanning Mirosc 10:425-434
36. Nakagawa Y, Abram V, Kezdy FJ, Kaiser ET, Coe FL (1983) Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine. J Biol Chem 258:12594-12600
37. Stapleton AMF, Ryall RL (1994) Crystal matrix protein-getting blood out of a stone. Miner Electrolyte Metab 20:399-409
38. Pillay NS, Asplin JR, Coe FL (1996) Purification and characterization of a human urinary S100 immunogen as a potent inhibitor of calcium oxalate monohydrate crystal growth and aggregation. In: Resnick MI, Preminger GM (eds) Urolithiasis 1996, Proc 8th Int Symp on Urolithiasi, Pak CYC, Millet The Printer, Inc, Dallas, TX, pp 301-302
39. Umekawa T, Kurita T (1994) Calprotectin-like protein is related to soluble organic matrix in calcium oxalate urinary stone. Biochem Mol Biol Int 34:309-313
40. Hess B (1994) Tamm-Horsfall glycoprotein and calcium nephrolithiasis. Miner Electrolyte Metab 20:393-398
41. Boeve ER, Cao LC, Verkoelen CF, Romijn JC, de Bruijn WC, Schroeder FH (1994) Glycosaminoglycans and other sulfated polysaccharides in calculogenesis of urinary stones. World J Urol 12:43-48